Production (Stage)
Burning Rock Biotech Limited
BNR
$3.56
$0.17415.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | -82.29M | -82.29M |
| Total Depreciation and Amortization | -- | -- | -- | 18.21M | 18.21M |
| Total Amortization of Deferred Charges | -- | -- | -- | 269.80K | 269.80K |
| Total Other Non-Cash Items | -- | -- | -- | 45.36M | 45.36M |
| Change in Net Operating Assets | -- | -- | -- | -7.22M | -7.22M |
| Cash from Operations | -- | -- | -- | -25.67M | -25.67M |
| Capital Expenditure | -- | -- | -- | -1.12M | -1.12M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 11.60K | 11.60K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 41.00K | 41.00K |
| Cash from Investing | -- | -- | -- | -1.07M | -1.07M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -6.98M | -6.98M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -41.82M | -41.82M |
| Cash from Financing | -- | -- | -- | -6.74M | -6.74M |
| Foreign Exchange rate Adjustments | -- | -- | -- | 1.28M | 1.28M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -32.21M | -32.21M |